Academic Content and Language Evaluation of This Article
CrossCheck and Google Search of This Article
Academic Rules and Norms of This Article
Citation of this article
Corresponding Author of This Article
Research Domain of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (6704)
All Articles published online
|
Publishing Process of This Article
|
Apr 28, 2015 (publication date) through Apr 25, 2024
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Hepatology
ISSN
1948-5182
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | Kasırga E. Lamivudine resistance in children with chronic hepatitis B. World J Hepatol 2015; 7(6): 896-902 [PMID: 25937866 DOI: 10.4254/wjh.v7.i6.896] |
|---|---|
| URL: | https://www.wjgnet.com/1007-9327/full/v7/i6/896.htm |
| Number | Citing Articles |
| 1 |
Małgorzata Pawłowska, Krzysztof Domagalski, Beata Smok, Paweł Rajewski, Magdalena Wietlicka-Piszcz, Waldemar Halota, Andrzej Tretyn, Alejandro Escobar-Gutiérrez. Continuous up to 4 Years Entecavir Treatment of HBV-Infected Adolescents – A Longitudinal Study in Real Life. PLOS ONE 2016; 11(9): e0163691 doi: 10.1371/journal.pone.0163691
|
| 2 |
Yachao Tao, Dongbo Wu, Lingyun Zhou, Enqiang Chen, Changhai Liu, Xiaoqiong Tang, Wei Jiang, Ning Han, Hong Li, Hong Tang. Hepatitis B Virus Infection. Advances in Experimental Medicine and Biology 2020; 1179: 137 doi: 10.1007/978-981-13-9151-4_6
|
| 3 |
José J. García-Trejo, Raquel Ortega, Mariel Zarco-Zavala. Putative Repurposing of Lamivudine, a Nucleoside/Nucleotide Analogue and Antiretroviral to Improve the Outcome of Cancer and COVID-19 Patients. Frontiers in Oncology 2021; 11 doi: 10.3389/fonc.2021.664794
|
| 4 |
Bikrant Bihari Lal, Vikrant Sood, Rajeev Khanna, Dinesh Rawat, Sanjeev Verma, Seema Alam. Pegylated interferon-based sequential therapy for treatment of HBeAg reactive pediatric chronic hepatitis B—First study in children. Indian Journal of Gastroenterology 2018; 37(4): 326 doi: 10.1007/s12664-018-0878-1
|
| 5 |
Chien-Yu Chen, Christina Hajinicolaou, Priya Walabh, Luicer Anne Olubayo Ingasia, Ernest Song, Anna Kramvis. Molecular characterization of hepatitis B virus (HBV) isolated from a pediatric case of acute lymphoid leukemia, with a delayed response to antiviral treatment: a case report. BMC Pediatrics 2022; 22(1) doi: 10.1186/s12887-022-03204-6
|
| 6 |
Huihui Yang, Weiwei Yao, Jinfei Yang. Overview of the development of HBV small molecule inhibitors. European Journal of Medicinal Chemistry 2023; 249: 115128 doi: 10.1016/j.ejmech.2023.115128
|
| 7 |
Kyung Jae Lee, Byung-Ho Choe, Jae Young Choe, Ju Young Kim, In Sook Jeong, Ju Whi Kim, Hye Ran Yang, Ju Yuong Chang, Kyung Mo Kim, Jin Soo Moon, Jae Sung Ko. A Multicenter Study of the Antiviral Efficacy of Entecavir Monotherapy Compared to Lamivudine Monotherapy in Children with Nucleos(t)ide-naïve Chronic Hepatitis B. Journal of Korean Medical Science 2018; 33(8) doi: 10.3346/jkms.2018.33.e63
|
| 8 |
Haruki Komatsu, Ayano Inui, Sachiyo Yoshio, Tomoo Fujisawa. Pharmacotherapy options for managing hepatitis B in children. Expert Opinion on Pharmacotherapy 2021; 22(4): 449 doi: 10.1080/14656566.2020.1841165
|